Crystal structures of archaemetzincin reveal a moldable substrate-binding site.

BACKGROUND: Archaemetzincins are metalloproteases occurring in archaea and some mammalia. They are distinct from all the other metzincins by their extended active site consensus sequence HEXXHXXGXXHCX(4)CXMX(17)CXXC featuring four conserved cysteine residues. Very little is known about their biologi...

Full description

Bibliographic Details
Main Authors: Christine Graef, Magdalena Schacherl, Sandro Waltersperger, Ulrich Baumann
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3427221?pdf=render
id doaj-683d029b6c714758a9dab952248a4dc0
record_format Article
spelling doaj-683d029b6c714758a9dab952248a4dc02020-11-25T01:53:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0178e4386310.1371/journal.pone.0043863Crystal structures of archaemetzincin reveal a moldable substrate-binding site.Christine GraefMagdalena SchacherlSandro WalterspergerUlrich BaumannBACKGROUND: Archaemetzincins are metalloproteases occurring in archaea and some mammalia. They are distinct from all the other metzincins by their extended active site consensus sequence HEXXHXXGXXHCX(4)CXMX(17)CXXC featuring four conserved cysteine residues. Very little is known about their biological importance and structure-function relationships. PRINCIPAL FINDINGS: Here we present three crystal structures of the archaemetzincin AfAmzA (Uniprot O29917) from Archaeoglobus fulgidus, revealing a metzincin architecture featuring a zinc finger-like structural element involving the conserved cysteines of the consensus motif. The active sites in all three structures are occluded to different extents rendering the enzymes proteolytically inactive against a large variety of tested substrates. Owing to the different ligand binding there are significant differences in active site architecture, revealing a large flexibility of the loops covering the active site cleft. CONCLUSIONS: The crystal structures of AfAmzA provide the structural basis for the lack of activity in standard proteolytic assays and imply a triggered activity onset upon opening of the active site cleft.http://europepmc.org/articles/PMC3427221?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Christine Graef
Magdalena Schacherl
Sandro Waltersperger
Ulrich Baumann
spellingShingle Christine Graef
Magdalena Schacherl
Sandro Waltersperger
Ulrich Baumann
Crystal structures of archaemetzincin reveal a moldable substrate-binding site.
PLoS ONE
author_facet Christine Graef
Magdalena Schacherl
Sandro Waltersperger
Ulrich Baumann
author_sort Christine Graef
title Crystal structures of archaemetzincin reveal a moldable substrate-binding site.
title_short Crystal structures of archaemetzincin reveal a moldable substrate-binding site.
title_full Crystal structures of archaemetzincin reveal a moldable substrate-binding site.
title_fullStr Crystal structures of archaemetzincin reveal a moldable substrate-binding site.
title_full_unstemmed Crystal structures of archaemetzincin reveal a moldable substrate-binding site.
title_sort crystal structures of archaemetzincin reveal a moldable substrate-binding site.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description BACKGROUND: Archaemetzincins are metalloproteases occurring in archaea and some mammalia. They are distinct from all the other metzincins by their extended active site consensus sequence HEXXHXXGXXHCX(4)CXMX(17)CXXC featuring four conserved cysteine residues. Very little is known about their biological importance and structure-function relationships. PRINCIPAL FINDINGS: Here we present three crystal structures of the archaemetzincin AfAmzA (Uniprot O29917) from Archaeoglobus fulgidus, revealing a metzincin architecture featuring a zinc finger-like structural element involving the conserved cysteines of the consensus motif. The active sites in all three structures are occluded to different extents rendering the enzymes proteolytically inactive against a large variety of tested substrates. Owing to the different ligand binding there are significant differences in active site architecture, revealing a large flexibility of the loops covering the active site cleft. CONCLUSIONS: The crystal structures of AfAmzA provide the structural basis for the lack of activity in standard proteolytic assays and imply a triggered activity onset upon opening of the active site cleft.
url http://europepmc.org/articles/PMC3427221?pdf=render
work_keys_str_mv AT christinegraef crystalstructuresofarchaemetzincinrevealamoldablesubstratebindingsite
AT magdalenaschacherl crystalstructuresofarchaemetzincinrevealamoldablesubstratebindingsite
AT sandrowaltersperger crystalstructuresofarchaemetzincinrevealamoldablesubstratebindingsite
AT ulrichbaumann crystalstructuresofarchaemetzincinrevealamoldablesubstratebindingsite
_version_ 1724990953596387328